Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 185, 71-79
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (16H04912)
This publication has 45 references indexed in Scilit:
- Vitamin D: Deficiency, Sufficiency and ToxicityNutrients, 2013
- Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediationExpert Opinion on Drug Metabolism & Toxicology, 2010
- Involvement of Vitamin D Receptor in the Intestinal Induction of Human ABCB1Drug Metabolism and Disposition, 2009
- 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ cultureBreast Cancer Research and Treatment, 2008
- Selective use of multiple vitamin D response elements underlies the 1 ,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 geneNucleic Acids Research, 2007
- Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalaciaJournal of Clinical Investigation, 2006
- Metabolism of vitamin D by human microsomal CYP2R1Biochemical and Biophysical Research Communications, 2004
- Metabolism of Vitamin D3 by Human CYP27A1Biochemical and Biophysical Research Communications, 2000
- Molecular Cloning of cDNA and Genomic DNA for Human 25-hydroxyvitamin D31α-hydroxylaseBiochemical and Biophysical Research Communications, 1997
- Stereochemistry of 25‐hydroxyvitamin D3—26,23‐lactone and 1α,25—dihydroxyvitamin D3—26,23‐lactone in rat serumFEBS Letters, 1981